Physician profile
Robert H Shaw
NPI 1902877533
$3,149.24
in general payments reported to CMS, 2019-2025
24 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $312 · 2021: $364 · 2022: $315 · 2023: $105 · 2024: $1,576 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,104 · Food and Beverage: $686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,104.07 |
| Food and Beverage | $686.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,451.67 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Ethicon US, LLC | $895.17 | 2019-2025 | Echelon; Endopath, Echelon Endopath, Stratafix |
| Takeda Pharmaceuticals U.S.A., INC. | $106.88 | 2021-2023 | Gattex |
| Kci USA, INC. | $105.51 | 2019-2023 | V.A.C. Dermatac, V.A.C. Veraflo, Activ.A.C. |
| Innocoll Pharmaceuticals Limited | $85.82 | 2021-2022 | |
| Smith+Nephew, INC. | $66.46 | 2019-2021 | |
| Molnlycke Health Care US, LLC | $60.01 | 2022 | |
| Tela Bio, INC. | $54.86 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $40.07 | 2022 | |
| Allergan, INC. | $34.91 | 2019 | |
| Medtronic, INC. | $31.50 | 2021-2022 | |
| Covidien LP | $24.13 | 2019-2020 | |
| Kerecis Limited | $22.85 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Polynovo North America LLC | $22.69 | 2024 | Novosorb Btm |
| Medtronic Vascular, INC. | $19.20 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $18.73 | 2022 | |
| Acell, INC. | $18.45 | 2020 | |
| Misonix INC | $16.44 | 2019 | |
| Boston Scientific Corporation | $15.13 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $14.03 | 2023 | Seglentis |
| Integra Lifesciences Corporation | $13.24 | 2022 | |
| Elutia, INC. | $11.69 | 2019 | |
| Stryker Corporation | $11.18 | 2019 | |
| Bolder Surgical LLC | $8.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.